INTELLIGENCE IN ACTION

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

November 14, 2018

Good news on the health IT front: The Surescripts Network Alliance™ is serving the needs of both providers and patients by delivering prescription price transparency and patient-specific benefit information at the point of care. This breakthrough technology is available now, and it’s catching on at an impressive rate.

Since its launch last year, there has been a 40-fold increase in the number of prescribers who have used Real-Time Prescription Benefit—a total of 30 million times—to view patient-specific prescription price information, plus therapeutic alternatives, within their electronic health record (EHR).

The solution’s rapid rate of growth is driven by collaboration across the network with several EHR software vendors and pharmacy benefit managers (PBMs) adopting or going live with Real-Time Prescription Benefit in recent months.  

EHRs representing 77 percent of U.S. prescribers have already signed on, including Allscripts, Aprima Medical Software, Cerner, eClinicalWorks, Epic, Modernizing Medicine and NextGen Healthcare.

Real-Time Prescription Benefit provides patient benefit data directly from leading PBMs and health plans, including CVS Health, DST, which was acquired by SS&C Technologies, Express Scripts and Navitus, who collectively reach 70 percent of U.S. covered lives.

It’s simple: Easing the way for patients to pick up and begin their medications makes them more likely to adhere to their treatment plans. And improved medication adherence improves the quality, safety and cost of healthcare across the board.

Watch the video below to see how Real-Time Prescription Benefit is a breakthrough technology that solves a major healthcare challenge.


Read the latest press release to learn more about how Surescripts is improving the prescribing experience for thousands of providers and patients across the country.

Related Articles

March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...
February 18, 2020

Patients Are Ready to Talk Dollars with Their Doctors

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX